166 related articles for article (PubMed ID: 30531601)
1. Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran: A Cross-sectional Study.
Tavousi F; Sadeghi A; Darakhshandeh A; Moghaddas A
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e146-e151. PubMed ID: 30531601
[TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study.
Hadjibabaie M; Badri S; Ataei S; Moslehi AH; Karimzadeh I; Ghavamzadeh A
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1619-27. PubMed ID: 23589317
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
5. Drug interactions in oncology: how common are they?
Riechelmann RP; Del Giglio A
Ann Oncol; 2009 Dec; 20(12):1907-12. PubMed ID: 19713244
[TBL] [Abstract][Full Text] [Related]
6. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
7. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation.
Rodrigues J; Marques P; Gomes C; Portela C
Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug Interactions in hospitalized cancer patients: A report from the Middle-East.
Moghaddas A; Adib-Majlesi M; Sabzghabaee AM; Hajigholami A; Riechelmann R
J Oncol Pharm Pract; 2021 Jan; 27(1):46-53. PubMed ID: 32183585
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Drug Interactions in Hospitalized Patients with Malignancy.
Hatefi S; Kadkhodaei A; Nejati B; Ghaffary S
Int J Hematol Oncol Stem Cell Res; 2022 Oct; 16(4):224-230. PubMed ID: 36883112
[TBL] [Abstract][Full Text] [Related]
11. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
[TBL] [Abstract][Full Text] [Related]
12. A survey of attitudes, practices, and knowledge regarding drug-drug interactions among medical residents in Iran.
Nabovati E; Vakili-Arki H; Taherzadeh Z; Saberi MR; Abu-Hanna A; Eslami S
Int J Clin Pharm; 2017 Jun; 39(3):560-568. PubMed ID: 28382584
[TBL] [Abstract][Full Text] [Related]
13. Potential Drug Interactions in Terminally-Ill Cancer Patients, a Report from the Middle East.
Mahzoni H; Naghsh E; Sharifi M; Moghaddas A; Momenzadeh M; Moghaddas A
J Pain Palliat Care Pharmacother; 2023 Dec; 37(4):278-285. PubMed ID: 37712672
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
[TBL] [Abstract][Full Text] [Related]
15. Impact of Clinical Pharmacist's Interventions on Potential Drug-Drug Interactions in the Cardiac Care Units of Two University Hospitals in Shiraz, South of Iran.
Shafiekhani M; Moosavi N; Firouzabadi D; Namazi S
J Res Pharm Pract; 2019; 8(3):143-148. PubMed ID: 31728345
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
Laban AA; Birand N; Chukwunyere U; Abdi A; Basgut B
Niger J Clin Pract; 2021 Jul; 24(7):1067-1071. PubMed ID: 34290184
[TBL] [Abstract][Full Text] [Related]
17. Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, Uganda.
Luzze B; Atwiine B; Lugobe HM; Yadesa TM
BMC Cancer; 2022 Dec; 22(1):1266. PubMed ID: 36471270
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials.
Marcath LA; Coe TD; Hoylman EK; Redman BG; Hertz DL
BMC Cancer; 2018 Nov; 18(1):1155. PubMed ID: 30466416
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.
Fernández de Palencia Espinosa MA; Díaz Carrasco MS; Fuster Soler JL; Ruíz Merino G; De la Rubia Nieto MA; Espuny Miró A
Int J Clin Pharm; 2014 Dec; 36(6):1160-9. PubMed ID: 25204258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
